The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Successful Treatment of Adult-Onset Dermatitis Herpetiformis with Low Dose Naltrexone
Open Journal of Clinical and Medical Case Reports
August 2017
https://www.researchgate.net/publication/319653170_Successful_treatment_of_adult-onset_dermatitis_herpetiformis_with_low_dose_naltrexone
Leonard Weinstock, MD - Celiac Disease (2017 Conference) (LDN, low dose naltrexone)
Celiac disease is a remarkable condition. It can present in so many different ways and have so many symptoms. What we're going to try is to hone down on the autoimmune conditions that are associated with it, which don't get as much attention in the literature as they should.
Dr Melissa Coats, LDN Radio Show 14 Nov 2018 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Linda Elsegood: Today my guest is Dr Melissa Coats from Arizona in the US. She is a naturopathic oncologist. Thank you for joining us today, Melissa.
Melissa Coats: Thank you for having me.
Dickson Chemist developed a new formulation of LDN which will hopefully improve the outcomes for patients. This new formulation is a more concentrated liquid in the form of drops which are administered under the tongue and absorbed directly from the mucosal lining of the mouth. This sublingual route produces a more rapid absorption bypassing the liver and digestive tract. There are several potential advantages to this, the drug may be more effective and will not be affected by the presence of food stuffs or the hostile environment of the gut.